5-aryl-indan-1-one oximes and analogs useful as progesterone...

Details 5-aryl-indan-1-one oximes and analogs useful as progesterone... 5-aryl-indan-1-one oximes and analogs useful as progesterone...

2006-09-18

2008-08-19

Anderson, Rebecca L (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C548S122000, C548S127000, C548S128000, C548S131000, C548S134000, C548S136000, C548S143000, C548S559000

Reexamination Certificate

active

07414142

ABSTRACT:
Compounds of formula I, wherein R1-R9and n are defined herein, and pharmaceutical compositions and kits containing these compounds are provided.Also provided are methods of inducing contraception, providing hormone replacement therapy, treating cycle-related symptoms, or treating or preventing benign or malignant neoplastic disease using the compounds of formula I or formula II, wherein R3-R5, R10, and R11are defined herein.

REFERENCES:
patent: 5329050 (1994-07-01), Weisse et al.
patent: 5360936 (1994-11-01), Weisse et al.
patent: 5578646 (1996-11-01), Pineyro-Lopez
patent: 5719136 (1998-02-01), Chwalisz et al.
patent: 6288126 (2001-09-01), LeSuisse et al.
patent: 6355648 (2002-03-01), Fensome et al.
patent: 6391907 (2002-05-01), Fensome et al.
patent: 6417214 (2002-07-01), Ullrich et al.
patent: 6436929 (2002-08-01), Zhang et al.
patent: 6509334 (2003-01-01), Zhang et al.
patent: 6521657 (2003-02-01), Fensome et al.
patent: 6566358 (2003-05-01), Zhang et al.
patent: 6583145 (2003-06-01), Fensome et al.
patent: 6608068 (2003-08-01), Fensome et al.
patent: 6713478 (2004-03-01), Zhang et al.
patent: 6835744 (2004-12-01), Ullrich et al.
patent: 6841568 (2005-01-01), Fensome et al.
patent: 6946454 (2005-09-01), Fensome et al.
patent: 7081457 (2006-07-01), Zhang et al.
patent: 7084168 (2006-08-01), Fensome et al.
patent: 7091234 (2006-08-01), Fensome et al.
patent: 2004/0186101 (2004-09-01), Zhang et al.
patent: 2004/0254186 (2004-12-01), Dean et al.
patent: 2005/0085470 (2005-04-01), Zhang et al.
patent: 2005/0171186 (2005-08-01), Fensome et al.
patent: 2006/0030615 (2006-02-01), Fensome et al.
patent: 2006/0142280 (2006-06-01), Zhang et al.
patent: 2006/0160882 (2006-07-01), Fensome et al.
patent: 467407 (1995-11-01), None
patent: 0568879 (1996-07-01), None
patent: 587107 (1996-08-01), None
patent: 1175397 (2004-08-01), None
patent: 2 705 671 (1994-02-01), None
patent: WO 97/27846 (1997-07-01), None
patent: WO 98/13061 (1998-04-01), None
patent: WO 98/22436 (1998-05-01), None
patent: WO 98/44797 (1998-10-01), None
patent: WO 98/09940 (1998-12-01), None
patent: WO 99/18079 (1999-04-01), None
patent: WO 99/61413 (1999-12-01), None
patent: WO 00/37433 (2000-06-01), None
patent: WO 00/66554 (2000-11-01), None
patent: WO 00/66555 (2000-11-01), None
patent: WO 00/66556 (2000-11-01), None
patent: WO 00/66570 (2000-11-01), None
patent: WO 00/66571 (2000-11-01), None
patent: WO 00/78724 (2000-12-01), None
patent: WO 03/091225 (2003-11-01), None
patent: WO 2006/023107 (2006-03-01), None
Horwitz et al, Progestins, Progesterone Receptors, and Breast Cancer, Hormones and Cancer, 283-306, 1996.
Kekkonen et al, Sequential Regimen of the Antiprogesterone RU486 and Synthetic Progestin for Contraception, Fertility and Sterility, vol. 60, No. 4, (Oct. 1993).
Kettel et al, Endocrine Responses to Long-term Administration of the Antiprogesterone RU486 in Patients with Pelvic Endometriosis, Fertility and Sterility, vol. 56, No. 3, (Sep. 1991).
Mangelsdorf et al, The Nuclear Receptor Superfamily: The Second Decade, Cell, vol. 83, 835-839, (Dec. 15, 1995).
Michna et al, Differentiation Therapy with Progesterone Antagonists, Ann. N.Y. Acad. Sci. 761, 224, (1995).
Murphy et al, Regression of Uterine Leiomyomata in Response to the Antiprogesterone RU 486*, Journal of Clinical Endocrinology and Metabolism, vol. 76, No. 2, 513-517, (1993).
Ulmann et al, Clinical Uses of Mifepristone (MFP), Ann. N.Y. Acad. Sci. 261, 248, (1995).

Affiliated with

Also associated with

Rating

5-aryl-indan-1-one oximes and analogs useful as progesterone... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5-aryl-indan-1-one oximes and analogs useful as progesterone..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-aryl-indan-1-one oximes and analogs useful as progesterone... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3999923